HomeACTU • NASDAQ
Actuate Therapeutics Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.56M | -13.87% |
Net income | -6.45M | 15.32% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.64M | 192.08% |
Total assets | 9.32M | 211.07% |
Total liabilities | 9.21M | 23.59% |
Total equity | 104.19K | — |
Shares outstanding | 19.53M | — |
Price to book | 691.00 | — |
Return on assets | -139.07% | — |
Return on capital | -600.34% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -6.45M | 15.32% |
Cash from operations | -4.77M | 13.42% |
Cash from investing | — | — |
Cash from financing | -109.41K | — |
Net change in cash | -4.88M | 11.43% |
Free cash flow | -2.43M | — |
Previous close
$6.91
Day range
$6.35 - $7.31
Year range
$5.52 - $11.73
Market cap
140.82M USD
Avg Volume
32.26K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2015
Headquarters
Website
Employees
10
